Jacqueline Corrigan-Curay, the acting director of the Center for Drug Evaluation and Research wrote in an email to colleagues that she will be retiring from the agency in July.
Nicholas M. Jaidar was named senior administrator for oncology at the Department of Oncology at the Johns Hopkins University School of Medicine and the Johns Hopkins Hospital.
Phyllis Harris was appointed chief legal and risk officer of American Cancer Society, effective June 23.
Matt Kozlovac was named the inaugural executive director of Man Up to Cancer, a national nonprofit dedicated to providing social and emotional support for men facing cancer.
Sethuraman Panchanathan, director of the National Science Foundation, will resign from the position 16 months before the scheduled end of his six-year term.
Credit: OHSU/Christine Torres HicksAfter a year as director of the Oregon Health and Science University’s Knight Cancer Institute, Tom Sellers has stepped down from his position. He is replaced by Lisa Coussens, chair of the Department of Cell, Developmental & Cancer Biology, who was appointed interim center director.
Dian Wang, William Tseng, and Brian A. Van Tine were appointed to NRG Oncology’s newly formed Sarcoma Subcommittee. Clifton (Dave) Fuller was named vice chair for NRG’s Imaging Committee.
The University of Texas MD Anderson Cancer Center received a $9 million gift from the F. W. Bert and Mae Dean Wheeler Foundation to establish the F. W. Bert and Mae Dean Wheeler Nurse Leadership Academy.
W. Kimryn Rathmell has stepped down as NCI director, opting to hand her resignation to the Biden administration over facing the uncertainties that Trump and his team are expected to usher in starting next week.
Lucio Miele will serve as director of the LSU LCMC Health Cancer Center. This announcement follows the current director Joe Ramos’ acceptance of an executive leadership position at the Lundquist Institute in California.
